Trident Ltd
NSE: TRIDENTCompany page on Cofacto
Open the Trident Ltd page

Trident Ltd Q2 FY27 Results Analysis: PAT Surges 93%, EBITDA Margin Expands 652 bps

Cofacto Research Published November 02, 2026 3 min read
Positive

Trident Ltd's Q2 FY27 numbers came in strong, with revenue of Rs. 1,719.48 Cr (-3.79% YoY) and PAT growth of +93.09% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateNovember 02, 2026
Revenue (Q2)Rs. 1,719.48 Cr (-3.79% YoY)
PAT (Q2)Rs. 175.58 Cr (+93.09% YoY)
EBITDA margin19.37% (+652 bps YoY)
EPS (Q2)Rs. 0.34 (+88.89% YoY)

Quarter Snapshot

Trident delivered a high-quality profitability quarter with EBITDA margin at 19.37% (+652 bps YoY) and PAT up 93.09% YoY to Rs.175.58 Cr, driven by the Yarn segment's margin surge to 18.76%. The offset is a shrinking top line (revenue -3.79% YoY) on Towel weakness and a fourth straight Paper & Chemicals margin compression. FCF-funded deleveraging (net debt -Rs.422.55 Cr in six months) and the newly approved Rs.4,650 Cr capacity expansion set up the next phase.

Q2 FY27 Expectations vs Results

DriverExpected before resultsWhat happenedVerdict
Revenue"revenue reads in-line to modestly ahead"Rs.1,719.48 Cr, (3.79)% YoY, (3.77)% QoQContradicted
Margins"flat to modestly compressing on raw material"19.37% EBITDA margin vs 17.55% Q1 / 12.85% YoY — favourablyContradicted
Yarn realisation tailwind"realization tailwind for the Yarn segment"Yarn revenue +10.32% YoY; margin 18.76% vs 5.11%Played out
Towel stabilisation"whether the Q1 collapse to 5.27% stabilizes"5.71% vs 5.27% QoQPlayed out
P&C 4th straight YoY compression"the clearest unresolved negative"11.90% vs 17.44% YoYPlayed out
Finance costs a "steady support""remain steady supports"Rs.32.53 Cr, +30.85% YoYContradicted
Depreciation support"(−24.36% YoY per recap)"Rs.71.52 Cr, (13.71)% YoYPlayed out
US tariff / CETA effectsongoing headwind / tailwindNot addressed in the filing — remains open for the callNot observable

Read our full results preview.

Management Guidance vs Delivery

What management saidWhat happenedVerdict
Margin-improvement levers: premiumised differentiated products and company-wide conversion-cost reduction (Q4 FY26 investor presentation)Company-basis EBITDA margin 19.37%, third straight quarterly expansion (+652 bps YoY)Confirmed in direction
"Consistent dividend payout" commitment (investor presentations; Rs.0.50/share interim for FY27 per prior-quarter decks)No dividend action in the Q2 Board outcomes of November 02, 2026Too Early
Cost optimization to reduce conversion cost (Q4 FY26 deck)Other expenses (2.52)% YoY; employee costs (2.24)% YoY; raw materials +2.69% vs revenue (3.79)%Confirmed in direction

Key Investment Insights

Key Positives

  • EBITDA margin expanded 652 bps YoY to 19.37% (company definition), third consecutive quarterly expansion
  • PAT grew 93.09% YoY to Rs.175.58 Cr; PBT up 87.55% YoY
  • Yarn segment result rose over 4x YoY to Rs.191.19 Cr at an 18.76% margin (vs 5.11% a year ago)
  • Bedsheets revenue grew 19.19% YoY with margin recovering to 12.39% from 7.02%
  • H1 CFO of Rs.798.47 Cr was 2.39x PAT; FCF of Rs.696.39 Cr
  • Net debt reduced Rs.422.55 Cr in six months; net debt/equity at 0.15x vs 0.24x
  • Board approved Rs.4,650 Cr capacity expansion programme including 99,840 new spindles and a 1,99,680-spindle yarn facility at Dhar

Risk Factors

  • Towel revenue fell 21.11% YoY with margin at 5.71% vs 10.81% a year ago
  • Paper & Chemicals margin compressed to 11.90% from 17.44% YoY — fourth consecutive quarter of YoY compression
  • Consolidated revenue declined 3.79% YoY and 3.77% QoQ
  • Finance costs rose 30.85% YoY to Rs.32.53 Cr, reversing the prior finance-cost tailwind
  • Yarn margin surge is price-driven per external context; filing gives no price/volume split
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now